Related Experiment Videos
Marrow transplants from unrelated donors
J A Hansen1, C Anasetti, E Petersdorf
1Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Transplantation Proceedings
|June 1, 1994
Summary
Finding a marrow donor is improving, but disparities persist for non-Caucasian patients. Increased ethnic diversity in donor registries and global cooperation are crucial for equitable access to unrelated donor (URD) transplants.
Area of Science:
- Immunogenetics
- Hematology
- Transplantation Medicine
Background:
- Over 1 million HLA-A, B typed volunteers are available for marrow donation.
- The U.S. National Marrow Donor Program (NMDP) database contains HLA-A, B, DR phenotypes for over 186,000 donors.
- Current donor pools show a disproportionate success rate for Caucasian patients, highlighting ethnic disparities.
Purpose of the Study:
- To assess the current state of unrelated donor (URD) transplantation.
- To identify challenges and opportunities for improving donor access and transplant outcomes.
- To emphasize the need for increased ethnic diversity in donor registries.
Main Methods:
- Analysis of NMDP database for HLA-A, B, DR phenotypes and search success rates.
- Review of the impact of HLA matching on Graft-versus-Host Disease (GVHD) and survival.
- Evaluation of the role of DNA typing in donor selection and search efficiency.
Main Results:
- Fifty-one percent of preliminary searches yield at least one HLA-A, B, DR match.
- Successful searches disproportionately benefit Caucasian patients, indicating a need for greater ethnic diversity.
- Minor HLA mismatches do not appear to decrease survival, but increase GVHD risk.
- URD transplant survival is improving with better supportive care and GVHD control.
Conclusions:
- Substantial recruitment of diverse racial and ethnic groups is essential for equitable non-Caucasian donor matching.
- Enhanced international cooperation between registries is vital for a global marrow donor program.
- While URD transplant outcomes are improving, they remain less favorable than HLA-identical sibling transplants.